Skip to content
Home/Companies/Pharma/LEO Pharma

LEO Pharma

Pharma·Denmark·Active·5yr hold
Entry
2021
Hold
5yr
Status
Active

Who owns LEO Pharma?

LEO Pharma is a Danish Pharma company, currently owned by Nordic Capital since 2021.

Hand-verified · updated 2026-08-18

Open JSON · CC-BY
Nordic Capital
Investor
Nordic Capital
Nordic Capital Fund X · 2020 · Buyout

Key facts

HQDenmark
SectorPharma
StatusActive

More from Nordic Capital Fund X

Other portfolio companies in the same fund.

Ascot Lloyd
Active
FinancialsUK· 2022
Bilthouse
Active
FintechGermany· 2022
Care Fertility
Care Fertility
Active
HealthcareUK· 2022
Equashield
Active
MedTechUS· 2022
One Inc
One Inc
Active
InsurTechUS· 2022
Siteimprove
Siteimprove
Active
SaaSDenmark· 2022

More PE-backed in Pharma

Comparable pharma deals from other GPs.

Abacus Pharmaceuticals
Abacus Pharmaceuticals
Active
The Carlyle GroupUS
AdipoPharma
AdipoPharma
Active
Capital Grand EstFrance
Advantice Health
Advantice Health
Active
TA AssociatesUS
Alcala Farma
Active
Advent InternationalSpain
Alvogen
Alvogen
Active
CVC Capital Partners
Anovo
Anovo
Active
ArdianUS

Questions

Who owns LEO Pharma?

LEO Pharma is currently owned by Nordic Capital, through Nordic Capital Fund X, since 2021.

When did Nordic Capital acquire LEO Pharma?

Nordic Capital acquired LEO Pharma in 2021.

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue